References
- Adler T. K. A newly identified metabolic product of codeine: N‐demethylated codeine. J. Pharm. Exp. Therap. 1952; 106: 371
- Fraser H. F., Isbell H., Van Horn G. D. Human pharmacology and addiction liability of norcodeine. J. Pharm. Exptl. Therap. 1960; 129: 172
- Way E. L., Adler T. K. The biological disposition of morphine and its surrogates. Bull. World Health Org. 1962; 26: 51
- Schmerzler E., Yu W., Hewitt M. I., Greenblatt I. J. Gas chromatographic determination of codeine in serum and urine. J. Pharm. Sci. 1966; 55: 155
- Winek C. L., Collom W. D., Wecht C. H. Codeine fatality from cough syrup. Clin. Tox. 1970; 3: 97
- Elliott H. W., Parker K. D., Wright J. A., Nomof N. Actions and metabolism of heroin administered by continuous intravenous infusion to man. Clin. Pharm. Therap. 1971; 12: 806
- Elliott H. W., Hine C. H., Wright J. A., Parker K. D., unpublished results
- Chao J. M., Saferstein R., Manura J. Identification of heroin and its diluents by chemical ionization mass spectroscopy. Anal. Chem. 1974; 46: 296
- Baselt R. C., Allison D. J., Wright J. A., Scannell J., Stevens B. W. Acute heroin fatalities in San Francisco—demographic and toxicologic characteristics. West J. Med. 1975; 122: 455
- Adler T. K., Fujimoto J. M., Way E. L., Baker E. M. The metabolic fate of codeine in man. J. Pharm. Exptl. Therap. 1955; 114: 251
- Gleason M. N., Gosselin R. E., Hodge H. C., Smith R. P. Clinical Toxicology of Commercial Products3rd ed. Williams and Wilkins, Baltimore, Md. 1969
- Physicians' Desk Reference29th ed. Medical Economics Co., Oradell, N.J. 1975